PORTLAND, Ore., May 5 /PRNewswire/ -- The Oregon Bioscience Association (OBA) today announced the appointment of Paul Woloshin, MBA, Ph.D. as executive director of the 14-year old nonprofit organization. Woloshin will lead OBA in its mission to support and expand Oregon's geographically and scientifically diverse bioscience community, representing both commercial and academic members.
"This position is an opportunity to have a positive impact on the dynamic bioscience industry in Oregon," Woloshin said. "OBA has made major strides forward in recent years and I look forward to continuing and expanding those efforts in ways that improve the business outlook for our current and future members. Oregon has no shortage of viable bioscience companies that can benefit from OBA services to help them get them to the next success level."
Woloshin brings to OBA a broad range of management, scientific and financial experience within the bioscience industry, including his most recent post as Director of Finance and Administration for the Oregon Health and Science University Research Division. Previously, Woloshin spent two years as Director of Finance and Administration for OHSU's Vaccine and Gene Therapy Institute and was Chief Executive Officer for Northwest Neurologic Inc., where he successfully negotiated and completed the merger of Northwest Neurologic with Neurocrine Biosciences in 1998.
OBA Board Co-Chair Ann Bunnenberg will introduce Woloshin to members and the broader bioscience community at OBA's annual bioscience conference, taking place in conjunction with Intel's Science and Engineering Fair at the Oregon Convention Center May 10 from 7:30 a.m. to 5 p.m. The conference theme is "Bioscience Growth in Oregon: Collaboration, Innovation and Focus."
About the Oregon Bioscience Association
Founded in 1990, the Oregon Bioscience Association is a nonpartisan, independent organization dedicated to enabling growth and viability of bioscience companies in the state. Fundamental to this mission is the dissemination of accurate, relevant and unbiased information about member companies' science, technology and business development to key audiences, including the public. In the coming years, OBA will serve as a conduit between commercial bioscience organizations, academic research institutions and public policy makers to ensure open communication about issues relevant to each, and identify challenges and opportunities for growth of the state's bioscience industry.
Oregon Bioscience Association
CONTACT: Ann Bunnenberg, Co-Chair of OBA Board of Directors, andPresident of Electrical Geodesics, Inc., +1-503-234-1603; or Jenny Moede ofWaggener Edstrom Bioscience, +1-503-443-7000, or email@example.com, for OregonBioscience Association